Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation.

Goldsmith JR.

Healthcare (Basel). 2015 Apr 14;3(2):219-32. doi: 10.3390/healthcare3020219. Review.

2.

Calcium vitamin D3 supplementation in clinical practice: side effect and satisfaction.

Sanaei M, Banasiri M, Shafiee G, Rostami M, Alizad S, Ebrahimi M, Larijani B, Heshmat R.

J Diabetes Metab Disord. 2016 Mar 29;15:9. doi: 10.1186/s40200-016-0231-0. eCollection 2015.

3.

Calcium vitamin D3 supplementation in clinical practice: side effect and satisfaction.

Sanaei M, Banasiri M, Shafiee G, Rostami M, Alizad S, Ebrahimi M, Larijani B, Heshmat R.

J Diabetes Metab Disord. 2016 Mar 10;15:5. doi: 10.1186/s40200-016-0227-9. eCollection 2015. Erratum in: J Diabetes Metab Disord. 2017 Sep 18;16:39.

4.

Glucocorticoid-induced osteoporosis.

Briot K, Roux C.

RMD Open. 2015 Apr 8;1(1):e000014. doi: 10.1136/rmdopen-2014-000014. eCollection 2015. Review.

5.

Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Mirza F, Canalis E.

Eur J Endocrinol. 2015 Sep;173(3):R131-51. doi: 10.1530/EJE-15-0118. Epub 2015 May 13. Review.

6.

Diet and dermatology: the role of dietary intervention in skin disease.

Katta R, Desai SP.

J Clin Aesthet Dermatol. 2014 Jul;7(7):46-51. Review.

7.

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.

Kavanaugh A, Wells AF.

Rheumatology (Oxford). 2014 Oct;53(10):1742-51. doi: 10.1093/rheumatology/keu135. Epub 2014 Apr 10. Review.

8.

Rheumatoid arthritis and incident fracture in women: a case-control study.

Brennan SL, Toomey L, Kotowicz MA, Henry MJ, Griffiths H, Pasco JA.

BMC Musculoskelet Disord. 2014 Jan 9;15:13. doi: 10.1186/1471-2474-15-13.

9.

Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids.

Kohler MJ, Amezaga M, Drozd J, Crowley ST, Gulanski B, Anderson DR, Fraenkel L.

J Gen Intern Med. 2013 Jun;28(6):825-9. doi: 10.1007/s11606-013-2360-1. Epub 2013 Feb 13.

10.

Treatment of glucocorticoid-induced osteoporsis.

Mazziotti G, Giustina A, Canalis E, Bilezikian JP.

Ther Adv Musculoskelet Dis. 2009 Feb;1(1):27-34. doi: 10.1177/1759720X09343222.

11.

Vitamin D and bone health: potential mechanisms.

Laird E, Ward M, McSorley E, Strain JJ, Wallace J.

Nutrients. 2010 Jul;2(7):693-724. doi: 10.3390/nu2070693. Epub 2010 Jul 5. Review.

12.

Vitamin D status in gastrointestinal and liver disease.

Pappa HM, Bern E, Kamin D, Grand RJ.

Curr Opin Gastroenterol. 2008 Mar;24(2):176-83. doi: 10.1097/MOG.0b013e3282f4d2f3. Review.

13.

How to prevent steroid induced osteoporosis.

Sambrook PN.

Ann Rheum Dis. 2005 Feb;64(2):176-8. Review.

14.

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.

Scott EM, Gaywood I, Scott BB.

Gut. 2000 Jan;46 Suppl 1:i1-8. No abstract available.

15.

Management of bone disease in patients on long term glucocorticoid therapy.

Compston JE.

Gut. 1999 Jun;44(6):770-2. No abstract available.

16.
17.

Prevention of glucocorticoid induced osteoporosis.

Bijlsma JW.

Ann Rheum Dis. 1997 Sep;56(9):507-9. No abstract available.

Supplemental Content

Support Center